Pfizer recalls anti-smoking drug due to high levels of ingredient tied increased risk of cancer

Pfizer recalled its anti-smoking drug Chantix due to high levels of an ingredient that is tied to an increased risk of cancer. In a notice posted to the Food and Drug Administration’s (FDA) website on Thursday, Pfizer said it was recalling Chantix 0…